Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
Abstract Objective This study aims to determine the oncological effectiveness and adverse‐effect profile of the Moscow strain of intravesical bacille Calmette–Guérin (BCG) for intermediate and high‐risk non‐muscle invasive bladder cancer (NMIBC). Materials and methods We performed a retrospective se...
Saved in:
Main Authors: | Amandeep Arora, Sugam Godse, Mahendra Pal, Ankit Misra, Ravi Teja Sepuri, Naveen Thimiri Mallikarjun, Ajit Gujela, Sachin Patel, Anuj Sharma, Santosh Menon, Ganesh Bakshi, Gagan Prakash |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-06-01
|
Series: | BJUI Compass |
Subjects: | |
Online Access: | https://doi.org/10.1002/bco2.70034 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing compliance and efficacy in intravesical BCG therapy for non-muscle invasive bladder cancer: tailored strategies and clinical outcomes
by: G. Shubhankar, et al.
Published: (2025-01-01) -
Nucleotide Oligomerization Domain-like receptor 4 (NLR4) Gene Expression and Interleukin 1-β (IL 1-β) Level in Urine Samples Before and After Intravesical BCG Therapy For Treatment of Bladder Cancer
by: Ahmed Samar Abd Elmoaty Eissa, et al.
Published: (2021-01-01) -
Psoriasis exacerbation following intravesical BCG immunotherapy for bladder carcinoma: A case report
by: Yusuf Can Edek, et al.
Published: (2025-07-01) -
Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01) -
Predictive value of tumor invasion patterns on intravesical bacillus Calmette–Guérin response for stage T1 high-grade non-muscle-invasive bladder cancer
by: Ismail Ulus, et al.
Published: (2025-07-01)